Ontology highlight
ABSTRACT: Background
Particulate matter10 (PM10) can induce airway inflammation and fibrosis. Recently, chitinase-1 has been shown to play key roles in inflammation and fibrosis. We aimed to investigate the effects of chitinase-1 inhibitor in PM10-treated murine mice models.Methods
In female BALB/c mice, PM10 was intranasally administered six times over 3 weeks, and ovalbumin (OVA) was intraperitoneally injected and then intranasally administered. Chitinase-1 inhibitor (CPX) 6 times over 3 weeks or dexamethasone 3 times in the last week were intraperitoneally administered. Two days after the last challenges, mice were euthanized. Messenger RNA sequencing using lung homogenates was conducted to evaluate signaling pathways.Results
PM10 and/or OVA-induced airway inflammation and fibrosis murine models were established. CPX and dexamethasone ameliorated PM10 or PM10/OVA-induced airway hyper-responsiveness, airway inflammation, and fibrosis. CPX and dexamethasone also reduced levels of various inflammatory markers in lung homogenates. PM10 and OVA also induced changes in mRNA expression across an extreme range of genes. CPX and dexamethasone decreased levels of mRNA expression especially associated with inflammation and immune regulation. They also significantly regulated asthma and asthma-related pathways, including the JACK-STAT signaling pathway.Conclusions
Chitinase-1 suppression by CPX can regulate PM10- and OVA-induced and aggravated airway inflammation and fibrosis via an asthma-related signaling pathway.
SUBMITTER: Choi YJ
PROVIDER: S-EPMC10024831 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
Choi Yong Jun YJ Han Heejae H Lee Jae-Hyun JH Lee Jaeuk J Kim Chi Young CY Byun Min Kwang MK Cho Jae Hwa JH Park Hye Jung HJ
Respiratory research 20230318 1
<h4>Background</h4>Particulate matter<sub>10</sub> (PM<sub>10</sub>) can induce airway inflammation and fibrosis. Recently, chitinase-1 has been shown to play key roles in inflammation and fibrosis. We aimed to investigate the effects of chitinase-1 inhibitor in PM<sub>10</sub>-treated murine mice models.<h4>Methods</h4>In female BALB/c mice, PM<sub>10</sub> was intranasally administered six times over 3 weeks, and ovalbumin (OVA) was intraperitoneally injected and then intranasally administered ...[more]